I

Ingenium Pharmaceuticals GmbH

10 employees

Ingenium Pharmaceuticals AG is discovers and develops molecules for the treatment of neuronal and autoimmune diseases.

Basic info

biotechnology research

Biotechnology

1999

$44M

from 10 investors over 10 rounds

I

Ingenium Pharmaceuticals GmbH raised undisclosed on June 3, 2007

Investors: Thuja Capital

I

Ingenium Pharmaceuticals GmbH raised undisclosed on April 26, 2005

Investors: Federal Ministry of Education and Research, Germany

I

Ingenium Pharmaceuticals GmbH raised $44M on October 1, 2000

Investors: IKB Deutsche Industriebank AG, Sofinnova Partners, Bayern Kapital GmbH, Index Ventures and Deutsche Bank

I

Ingenium Pharmaceuticals GmbH raised undisclosed on January 1, 1999

Investors: AlpInvest Partners and Techno Venture Management

I

Ingenium Pharmaceuticals GmbH raised undisclosed on June 1, 1998

Investors: QIAGEN